Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.

<h4>Objectives</h4>To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage.<h4>Methods</h4>Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial spondy...

Full description

Bibliographic Details
Main Authors: Monika Hebeisen, Almut Scherer, Raphael Micheroli, Michael J Nissen, Giorgio Tamborrini, Burkhard Möller, Pascal Zufferey, Pascale Exer, Adrian Ciurea
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0216746

Internet

https://doi.org/10.1371/journal.pone.0216746

Similar Items